Registration Strip Icon for discussion Register to chat with like-minded investors on our interactive forums.

Cassava Sciences (SAVA)

Cassava Sciences Inc
Date:
Sort by:
 Showing the most relevant articles for your search:NASDAQ:SAVA
DateTimeSourceHeadlineSymbolCompany
09/01/202510:45PR Newswire (US)Shareholders of Cassava Sciences, Inc. Should Contact The Gross Law Firm Before February 10, 2025 to Discuss Your Rights - SAVANASDAQ:SAVACassava Sciences Inc
07/01/202521:40Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:SAVACassava Sciences Inc
06/01/202510:45PR Newswire (US)Cassava Sciences, Inc. Sued for Securities Law Violations - Investors Should Contact The Gross Law Firm Before February 10, 2025 to Discuss Your Rights - SAVANASDAQ:SAVACassava Sciences Inc
02/01/202516:48PR Newswire (US)Cassava Sciences, Inc. Class Action: The Gross Law Firm Reminds Cassava Sciences, Inc. Investors of the Pending Class Action Lawsuit with a Lead Plaintiff Deadline of February 10, 2025 - SAVANASDAQ:SAVACassava Sciences Inc
30/12/202410:45PR Newswire (US)Class Action Filed Against Cassava Sciences, Inc. (SAVA) - February 10, 2025 Deadline to Join - Contact The Gross Law FirmNASDAQ:SAVACassava Sciences Inc
26/12/202410:45PR Newswire (US)The Gross Law Firm Notifies Shareholders of Cassava Sciences, Inc.(SAVA) of a Class Action Lawsuit and an Upcoming DeadlineNASDAQ:SAVACassava Sciences Inc
23/12/202410:45PR Newswire (US)The Gross Law Firm Reminds Shareholders of a Lead Plaintiff Deadline of February 10, 2025 in Cassava Sciences, Inc. Lawsuit - SAVANASDAQ:SAVACassava Sciences Inc
19/12/202410:45PR Newswire (US)Class Action Filed Against Cassava Sciences, Inc. (SAVA) - February 10, 2025 Deadline to Join - Contact The Gross Law FirmNASDAQ:SAVACassava Sciences Inc
16/12/202410:45PR Newswire (US)Class Action Filed Against Cassava Sciences, Inc. (SAVA) - February 10, 2025 Deadline to Join - Contact The Gross Law FirmNASDAQ:SAVACassava Sciences Inc
03/12/202421:18Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:SAVACassava Sciences Inc
03/12/202421:16Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:SAVACassava Sciences Inc
02/12/202422:14Edgar (US Regulatory)Form 144 - Report of proposed sale of securitiesNASDAQ:SAVACassava Sciences Inc
29/11/202420:33Edgar (US Regulatory)Form 144 - Report of proposed sale of securitiesNASDAQ:SAVACassava Sciences Inc
26/11/202421:48Edgar (US Regulatory)Form SCHEDULE 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]NASDAQ:SAVACassava Sciences Inc
25/11/202412:35Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:SAVACassava Sciences Inc
20/11/202421:39Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:SAVACassava Sciences Inc
20/11/202421:37Edgar (US Regulatory)Form 3 - Initial statement of beneficial ownership of securitiesNASDAQ:SAVACassava Sciences Inc
20/11/202421:35Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:SAVACassava Sciences Inc
20/11/202421:33Edgar (US Regulatory)Form 3 - Initial statement of beneficial ownership of securitiesNASDAQ:SAVACassava Sciences Inc
07/11/202421:29Edgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]NASDAQ:SAVACassava Sciences Inc
07/11/202413:10Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:SAVACassava Sciences Inc
04/11/202421:09Edgar (US Regulatory)Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]NASDAQ:SAVACassava Sciences Inc
08/10/202412:10Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:SAVACassava Sciences Inc
01/10/202420:37Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:SAVACassava Sciences Inc
01/10/202420:07Edgar (US Regulatory)Form 8-K/A - Current report: [Amend]NASDAQ:SAVACassava Sciences Inc
27/09/202411:36Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:SAVACassava Sciences Inc
26/09/202422:15GlobeNewswire Inc.Cassava Sciences Resolves SEC InvestigationNASDAQ:SAVACassava Sciences Inc
24/09/202412:30GlobeNewswire Inc.Cassava Sciences Announces Completion of an Interim Safety Review of Oral Simufilam On-going Phase 3 TrialsNASDAQ:SAVACassava Sciences Inc
09/09/202412:30GlobeNewswire Inc.Cassava Sciences Names Rick Barry as Chief Executive OfficerNASDAQ:SAVACassava Sciences Inc
03/09/202412:31GlobeNewswire Inc.Cassava Sciences to Present at the H.C. Wainwright Global Investment ConferenceNASDAQ:SAVACassava Sciences Inc
 Showing the most relevant articles for your search:NASDAQ:SAVA